Oral Oncology
Volume 36, Issue 1 , Pages 67-69 , January 2000

Immunohistochemical Mdm2 expression in minor salivary gland tumours and its relationship to p53 gene status

  • V.C. de Araújo

      Affiliations

    • Disciplina de Patologia Oral, Faculdade de Odontologia, Universidade de São Paulo, Av. Prof. Lineu Prestes, 2227 São Paulo, SP, Brazil
    • Corresponding Author InformationCorresponding author. Tel./fax: +55-11-818-7894
    • ,
  • M.T. Martins

      Affiliations

    • Disciplina de Patologia Oral, Faculdade de Odontologia, Universidade de São Paulo, Av. Prof. Lineu Prestes, 2227 São Paulo, SP, Brazil
    • ,
  • K.R.M. Leite

      Affiliations

    • Sı́rio Libanês Hospital, Rua Dona Adma Jafet, 91, São Paulo, Brazil
    • ,
  • R.S. Gomez

      Affiliations

    • Oral Pathology Department, School of Dentistry, Federal University of Minas Gerais, Rua Conde de Linhares, 141, Belo Horizonte-MG, Brazil
    • ,
  • N.S. de Araújo

      Affiliations

    • Disciplina de Patologia Oral, Faculdade de Odontologia, Universidade de São Paulo, Av. Prof. Lineu Prestes, 2227 São Paulo, SP, Brazil

Received 16 June 1999 ,Accepted 22 July 1999.

References 

  1. Araujo VC, Loyola AM, Pinto DS, Borra RC, Araujo NS. p53 in biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system. European Journal of Cancer. 1997;33B:5–9
  2. Bocklage T, Feddersen R. Unusual mesenchymal and mixed tumors of the salivary gland. An immunohistochemical and flow cytometric analysis of three cases. Archives of Pathology and Laboratory Medicine. 1995;119:69–74
  3. Deguchi H, Hamano H, Hayashi Y. C-myc, ras and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands. Acta Pathologica Japonica. 1993;43:413–422
  4. Queiroz, L.M.G. Expressão do PCNA, Ki-67, c-erbB-2 e p53 no carcinoma adenóide cı́stico e adenocarcinoma polimórfico de baixo grau de malignidade de glândula salivar menor. Thesis, São Paulo, 1997
  5. Papadaki H, Finkelstein SD, Kounelis S, Bakker A, Swalsky PA, Kapadia SB. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Human Pathology. 1996;27:567–572
  6. Jones SN, Sands AT, Hancock A, et al.  The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of MDM2. Proceedings of National Academy of Science of United States of America. 1996;93:14 106–14 111
  7. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–299
  8. Kubbutat MHG, Jones SN, Vousden K. Regulation of p53 stability by Mdm2. Nature. 1997;387:299–303
  9. Sun P, Dong P, Dai K, Hannon GJ, Beach D. p53-independent role of MDM2 in TGF-beta1 resistance. Science. 1998;282:2270–2272
  10. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Amplification and over-expression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Research. 1993;54:2736–2739
  11. Leach FS, Tokino T, Meltzer P, et al.  p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Research. 1993;53:2231–2234
  12. McCann AH, Kirley A, Carney DN, et al.  Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. British Journal of Cancer. 1995;71:981–985
  13. Kawamata N, Miller C, Levy V, Shintaku IP, Koeffler HP, Said JW. MDM2 oncogene expression in non-Hodgkin's lymphomas. Diagnostic Molecular Pathology. 1996;5:33–38
  14. Pilotti S, Della Torri G, Lavarino C, et al.  Distinct MDM2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. Journal of Pathology. 1997;181:14–24
  15. Seifert G, Brocheriou C, Cardesa A, Eveson JW, Seifert G. WHO international histological classification of tumours. Tentative histological classification of salivary gland tumours. Pathology, Research and Practice. 1990;186:555–581
  16. Soong R, Iacopetta BJ. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Modern Pathology. 1997;10:252–258
  17. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New England Journal of Medicine. 1993;28:1318–1327
  18. Ishi K, Nakajima TT. Evaluation of malignant grade of salivary gland tumours: studies by cytofluorometric nuclear DNA analysis, histochemistry nucleolar organizer regions and immunohistochemistry for p53. Pathology International. 1994;44:287–296
  19. Kärjä VJ, Syrjänen KJ, Kurvinen AK, Syrjänen SM. Expression and mutations of p53 in salivary gland tumors. Journal of Oral Pathology and Medicine. 1997;26:217–223
  20. Momand J, Zambetti GP. MDM-2: “Big Brother” of p53. Journal of Cellular Biochemistry. 1997;64:343–352

PII: S1368-8375(99)00054-8

Oral Oncology
Volume 36, Issue 1 , Pages 67-69 , January 2000

Article Tools

* Image Usage & Resolution